Sign inJoin waitlistJoin the waitlist

Jasmine Zain

Attending Physician · New York Presbyterian Hospital

Credentials: · · · · · ·

History

Memorial Sloan Kettering Monmouth · Memorial Hospital for Cancer and allied Diseases
2025–Present

Hematology and Medical Oncology
NYU Langone Health
1990–1993
La Guardia Hospital
1987–1990
FATIMA JINNAH MED UNIV, LAHORE, PAKISTAN
1983–1987

Research

Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma
Journal of Clinical Oncology · 2009 · 597 citations
Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study
Journal of Clinical Oncology · 2011 · 539 citations
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
Blood · 2011 · 407 citations

Christiane Querfeld
37 papers
Steven Rosen
37 papers
Stephen Forman
26 papers
OO
Owen O’Connor
24 papers
SH
Steven Horwitz
22 papers
Leslie Popplewell
21 papers
AH
Alex Herrera
20 papers
AN
Auayporn Nademanee
14 papers
MM
Matthew Mei
13 papers
Francine Foss
12 papers
Joo Song
12 papers
FA
Farah Abdulla
11 papers

Clinical trials

Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma
Principal investigator · Completed · Phase 1
City of Hope Medical Center
2020–2024
Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell Lymphomas
Principal investigator · Withdrawn · Phase 1
City of Hope Medical Center
2019
Venetoclax and Romidepsin in Treating Patients With Recurrent or Refractory Mature T-Cell Lymphoma
Principal investigator · Completed · Phase 2
City of Hope Medical Center
2018–2023
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Site PI · Recruiting · Phase 1
Kyowa Kirin, Inc.
2026–2030